Diabetic Macular Edema (DME)
3 competing products in clinical development for Diabetic Macular Edema (DME).
Pipeline by Phase
Phase 22
Phase 31
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| CT-P42 + Eylea | Celltrion | Phase 3 | Completed | 40 |
| KHK4951 + Aflibercept Injection | Kyowa Kirin | Phase 2 | Active | 39 |
| UBX1325 | Unity Biotechnology | Phase 2 | Completed | 25 |